.png)
Diabetes Devices Market by Product - Global Industry Analysis and Forecast to 2027
Published On : May 2022 Pages : 133 Category: Medical Devices Report Code : HC053
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Industry Trend Analysis
Diabetes devices market is expected to be around $35 billion by 2027. This market has witnessed enormous growth in the past few years and is driven by increasing prevalence of diabetes, growing research on diabetes, low diagnosis rate, various government initiatives and international collaborations for diabetic research. Diabetes is fourth leading cause of death among people. As per World Health Organization (WHO), in 2017, around 422 million people were living with diabetes across the globe as compared to 108 million in 1980. This prevalence has almost double since 1980, growing from 4.7% to 8.5% in the adult population. Therefore, increasing incidence of diabetes due to changes in sedentary lifestyle is the major factor contributing to the market growth.
Advancement in technology and easy availability of wide range of user friendly devices has further enhanced the growth of this market. Diabetic devices market is innovation driven and majority of companies are focusing on innovation to develop user friendly devices which will further boost the growth of the market. However, high cost of production, availability of economical alternate treatments, low awareness about diabetes and its prevention, can hamper the market growth.
Product Outlook and Trend Analysis
Glucose monitoring and insulin delivery devices segment accounted for the largest share of the overall market in 2017. Glucose monitoring devices are used to monitor fluctuations in blood glucose levels. It includes continuous glucose monitoring devices such as blood glucose meters, blood glucose testing strips, and lancets. The market for glucose monitoring devices will show moderate growth in coming years whereas continuous glucose monitoring devices will show innovations leading to increase in demand of such products and are expected to grow at fastest rate over the forecast period.
Insulin delivery devices are those devices which are used to deliver insulin with devices such as insulin syringe, insulin pen, and insulin pump. The market share of insulin syringe will decrease whereas demand for insulin pen and insulin pump will substantially increase in next five years. This can be attributed to the regulatory framework to minimize needle related injuries, increased utilization of engineered devices, and patients looking for easy methods for insulin delivery in the body.
Regional Outlook and Trend Analysis
North America dominates the global market with highest share market in 2017. This is because of presence of large targeted population with high adoption of technologically advanced products. It will continue to maintain its leading position during the forecast period, due to rising adoption of home monitoring devices and developed healthcare infrastructure.
Asia-Pacific is expected to grow at the highest CAGR during the forecast period, due to high diabetic population and increase in disposable income of the people. Latin America is expected to be second fastest growing market because of developing economies such as Argentina and Brazil. With increase in awareness about diabetes and its treatment, increase in healthcare expenditures and various governments’ initiative will further boost the market growth.
Competitive Analysis
A large number of companies compete with each other to increase their market share and sustain their positions at global level. Therefore, they have been introducing large number of innovative and technologically advanced products to the market. For instance, in May 2017, Ascensia Diabetes Care obtained CE Mark for its new CONTOUR NEXT ONE and CONTOUR PLUS ONE blood glucose monitoring systems. This is one of the major developments in the evolution of self-monitoring of blood glucose for diabetic people.
Some of the major players in the market are Novo Nordisk A/S, Bayer Healthcare AG, Johnson & Johnson, Abbott Laboratories, Inc., F. Hoffmann La-Roche Ltd., Becton Dickinson and Company, Medtronic, Inc., and Sanofi.
Market Opportunities
The healthcare devices market is driven by technology and innovation. Companies are striving hard to design and developed products that will change the way in which diabetes is measured. Products like Bluetooth enable glucose monitoring devices, Smart insulin deliver devices which injects Insulin based on body requirement, devices to keep constant check on glucose with warning signals when glucose level fluctuates will soon be reality in market place. The market for diabetic devices will see tremendous growth with new products coming up that will enhance customer experience with ease of usage of products.
Diabetes Devices Market Segmentation
By Product:
- Monitoring and Diagnostic Devices
- Continuous Glucose Monitors
- Analog Glucose Meters
- Lancets
- Glucose Test Strips
- Insulin Delivery Devices
- Insulin Pens
- Insulin Injections
- Insulin Syringes
- Insulin Pumps
By Region:
- North America
- U.S
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- Rest of the World
- Brazil
- South Africa
- Saudi Arabia
- Turkey
- United Arab Emirates
- Others
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2022 to 2027?
- What will be the industry market growth from 2022 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
- Diabetes Devices Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
- Monitoring and Diagnostic Devices Market, By Type
- Lancets
- Analog Glucose Meter
- Continuous Glucose Monitors
- Glucose Test Strips
- Insulin Delivery Devices Market, By Type
- Insulin Syringes
- Insulin Pens
- Insulin Pumps
- Insulin Injections
- Diabetes Devices Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
- North America
- North America Diabetes Devices Market, By Country
- North America Diabetes Devices Market, By Product
- U.S. Diabetes Devices Market, By Product
- Canada Diabetes Devices Market, By Product
- Mexico Diabetes Devices Market, By Product
-
- Europe
- Europe Diabetes Devices Market, By Country
- Europe Diabetes Devices Market, By Product
- Germany Diabetes Devices Market, By Product
- France Diabetes Devices Market, By Product
- UK Diabetes Devices Market, By Product
- Italy Diabetes Devices Market, By Product
- Spain Diabetes Devices Market, By Product
- Rest of Europe Diabetes Devices Market, By Product
-
- Asia-Pacific
- Asia-Pacific Diabetes Devices Market, By Country
- Asia-Pacific Diabetes Devices Market, By Product
- Japan Diabetes Devices Market, By Product
- China Diabetes Devices Market, By Product
- Australia Diabetes Devices Market, By Product
- India Diabetes Devices Market, By Product
- South Korea Diabetes Devices Market, By Product
- Rest of Asia-Pacific Diabetes Devices Market, By Product
- Asia-Pacific
-
- Rest of the World
- Rest of the World Diabetes Devices Market, By Country
- Rest of the World Diabetes Devices Market, By Product
- Brazil Diabetes Devices Market, By Product
- South Africa Diabetes Devices Market, By Product
- Saudi Arabia Diabetes Devices Market, By Product
- Turkey Diabetes Devices Market, By Product
- United Arab Emirates Diabetes Devices Market, By Product
- Others Diabetes Devices Market, By Product
- Rest of the World
Table of Contents
1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Share Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.1.1. Rising Prevalence of Diabetes
3.3.1.2. Rise in Obese Population
3.3.1.3. Sedentary Lifestyle and Improper Diet
3.3.1.4. Technological Advancements
3.3.2. Restraints
3.3.2.1. High Cost Related to Diagnosis and Treatments
3.3.2.2. Unfavorable Reimbursement Policies for New Technologies
3.3.3. Opportunities
3.3.3.1. Emerging Market to Offer Lucrative Growth Opportunities
3.4. Industry Trends
3.5. Reimbursement Scenario
4. Diabetes Devices Market, By Product
4.1. Introduction
4.2. Diabetes Devices Market Assessment and Forecast, By Product, 2017-2027
4.3. Monitoring and Diagnostic Devices
4.3.1. Global Market Assessment and Forecast, By Type, 2017-2027 ($Million)
4.3.2. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.3.3. Lancets
4.3.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.3.4. Analog Glucose Meters
4.3.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.3.5. Continuous Glucose Monitors
4.3.5.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.3.6. Glucose Test Strips
4.3.6.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4. Insulin Delivery Devices
4.4.1. Market Assessment and Forecast, By Type, 2017-2027 ($Million)
4.4.2. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.3. Insulin Syringes
4.4.3.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.4. Insulin Pens
4.4.4.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.5. Insulin Pumps
4.4.5.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
4.4.6. Insulin Injections
4.4.6.1. Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5. Diabetes Devices Market, By Region
5.1. Introduction
5.2. Diabetes Devices Market Assessment and Forecast, By Region, 2017-2027 ($Million)
5.3. North America
5.3.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
5.3.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.3.2.1. U.S.
5.3.2.1.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.3.2.2. Canada
5.3.2.2.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.3.2.3. Mexico
5.3.2.3.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.4. Europe
5.4.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
5.4.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.4.2.1. Germany
5.4.2.1.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.4.2.2. France
5.4.2.2.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.4.2.3. UK
5.4.2.3.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.4.2.4. Italy
5.4.2.4.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.4.2.5. Spain
5.4.2.5.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.4.2.6. Russia
5.4.2.6.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.4.2.7. Rest of Europe
5.4.2.7.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.5. Asia-Pacific
5.5.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
5.5.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.5.2.1. Japan
5.5.2.1.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.5.2.2. China
5.5.2.2.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.5.2.3. Australia
5.5.2.3.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.5.2.4. India
5.5.2.4.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.5.2.5. South Korea
5.5.2.5.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.5.2.6. Taiwan
5.5.2.6.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.5.2.7. Rest of Asia-Pacific
5.5.2.7.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.6. Rest of the World
5.6.1. Market Assessment and Forecast, By Country, 2017-2027 ($Million)
5.6.2. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.6.2.1. Brazil
5.6.2.1.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.6.2.2. Turkey
5.6.2.2.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.6.2.3. Saudi Arabia
5.6.2.3.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.6.2.4. South Africa
5.6.2.4.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.6.2.5. United Arab Emirates
5.6.2.5.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
5.6.2.6. Others
5.6.2.6.1. Market Assessment and Forecast, By Product, 2017-2027 ($Million)
6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.1.1. Business Overview
6.1.2. Product Portfolio
6.1.3. Key Financials
6.1.4. Strategic Developments
6.2. Bayer Healthcare AG
6.2.1. Business Overview
6.2.2. Product Portfolio
6.2.3. Key Financials
6.2.4. Strategic Developments
6.3. Johnson & Johnson
6.3.1. Business Overview
6.3.2. Product Portfolio
6.3.3. Key Financials
6.3.4. Strategic Developments
6.4. F. Hoffmann La-Roche Ltd.
6.4.1. Business Overview
6.4.2. Product Portfolio
6.4.3. Key Financials
6.4.4. Strategic Developments
6.5. Becton Dickinson and Company
6.5.1. Business Overview
6.5.2. Product Portfolio
6.5.3. Key Financials
6.5.4. Strategic Developments
6.6. Medtronic, Inc.
6.6.1. Business Overview
6.6.2. Product Portfolio
6.6.3. Key Financials
6.6.4. Strategic Developments
6.7. Novo Nordisk A/S
6.7.1. Business Overview
6.7.2. Product Portfolio
6.7.3. Key Financials
6.7.4. Strategic Developments
6.8. Sanofi
6.8.1. Business Overview
6.8.2. Product Portfolio
6.8.3. Key Financials
6.8.4. Strategic Developments
6.9. Tandem Diabetes Care, Inc
6.9.1. Business Overview
6.9.2. Product Portfolio
6.9.3. Key Financials
6.9.4. Strategic Developments
6.10. Terumo Corporation
6.10.1. Business Overview
6.10.2. Product Portfolio
6.10.3. Key Financials
6.10.4. Strategic Developments
List of Tables
Table 1.Global Diabetes Devices Market, By Product ($Million), 2017-2025
Table 2.Monitoring and Diagnostic Devices Market, By Type ($Million), 2017-2025
Table 3.Monitoring and Diagnostic Devices Market, By Region ($Million), 2017-2025
Table 4.Lancets Market, By Region ($Million), 2017-2025
Table 5.Analog Glucose Meter Market, By Region ($Million), 2017-2025
Table 6.Continuous Glucose Monitors (CGM) Market, By Region ($Million), 2017-2025
Table 7.Glucose Test Strips Market, By Region ($Million), 2017-2025
Table 8.Global Insulin Delivery Devices Market, By Type ($Million), 2017-2025
Table 9.Insulin Delivery Devices Market, By Region ($Million), 2017-2025
Table 10.Insulin Syringes Market, By Region ($Million), 2017-2025
Table 11.Insulin Pens Market, By Region ($Million), 2017-2025
Table 12.Insulin Pumps Market, By Region ($Million), 2017-2025
Table 13.Insulin Injections Market, By Region ($Million), 2017-2025
Table 14.Diabetes Devices Market, By Region, 2017-2025 ($Million)
Table 15.North America Diabetes Devices Market, By Country, 2017-2025 ($Million)
Table 16.North America Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 17.U.S. Diabetes devices market, by product, 2017-2025 ($Million)
Table 18.Canada Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 19.Mexico Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 20.Europe Diabetes Devices Market, By Country, 2017-2025 ($Million)
Table 21.Europe Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 22.Germany Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 23.France Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 24.UK Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 25.Italy Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 26.Spain Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 27.Russia Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 28.Rest of Europe Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 29.Asia-Pacific Diabetes Devices Market, By Country, 2017-2025 ($Million)
Table 30.Asia-Pacific Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 31.Japan Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 32.China Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 33.Australia Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 34.India Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 35.South Korea Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 36.Taiwan Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 37.Rest of Asia-Pacific Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 38.Rest of the World Diabetes Devices Market, By Country, 2017-2025 ($Million)
Table 39.Rest of the World Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 40.Brazil Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 41.Turkey Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 42.Saudi Arabia Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 43.South Africa Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 44.United Arab Emirates Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 45.Others Diabetes Devices Market, By Product, 2017-2025 ($Million)
Table 46.Abbott Laboratories: Key Strategic Developments, 2017-2017
Table 47.Bayer Healthcare: Key Strategic Developments, 2017-2017
Table 48.Johnson & Johnson: Key Strategic Developments, 2017-2017
Table 49.Roche: Key Strategic Developments, 2017-2017
Table 50.BD: Key Strategic Developments, 2017-2017
Table 51.Medtronic: Key Strategic Developments, 2017-2017
Table 52.Novo Nordisk A/S: Key Strategic Developments, 2017-2017
Table 53.Sanofi: Key Strategic Developments, 2017-2017
Table 54.Tandem Diabetes Care, Inc: Key Strategic Developments, 2017-2017
Table 55.Terumo Corporation: Key Strategic Developments, 2017-2017
List of Figures
Figure 1.Global Diabetes Devices Market Share, By Product, 2017 & 2025
Figure 2.Diabetes Devices Market, By Region, 2017 ($Million)
Figure 3.Abbott Laboratories: Net Revenues, 2017-2017 ($Million)
Figure 4.Abbott Laboratories: Net Revenue Share, By Segment, 2017
Figure 5.Abbott Laboratories: Net Revenue Share, By Geography, 2017
Figure 6.Bayer Healthcare: Net Revenues, 2017-2017 ($Million)
Figure 7.Bayer Healthcare: Net Revenue Share, By Segment, 2017
Figure 8.Bayer Healthcare: Net Revenue Share, By Geography, 2017
Figure 9.Johnson & Johnson: Net Revenues, 2017-2017 ($Million)
Figure 10.Johnson & Johnson: Net Revenue Share, By Segment, 2017
Figure 11.Johnson & Johnson: Net Revenue Share, By Geography, 2017
Figure 12.Roche: Net Revenues, 2017-2017 ($Million)
Figure 13.Roche: Net Revenue Share, By Segment, 2017
Figure 14.Roche: Net Revenue Share, By Geography, 2017
Figure 15.BD: Net Revenues, 2017-2017 ($Million)
Figure 16.BD: Net Revenue Share, By Segment, 2017
Figure 17.BD: Net Revenue Share, By Geography, 2017
Figure 18.Medtronic: Net Revenues, 2017-2017 ($Million)
Figure 19.Medtronic: Net Revenue Share, By Segment, 2017
Figure 20.Medtronic: Net Revenue Share, By Geography, 2017
Figure 21.Novo Nordisk A/S: Net Revenues, 2017-2017 ($Million)
Figure 22.Novo Nordisk A/S: Net Revenue Share, By Segment, 2017
Figure 23.Novo Nordisk A/S: Net Revenue Share, By Geography, 2017
Figure 24.Sanofi: Net Revenues, 2017-2017 ($Million)
Figure 25.Sanofi: Net Revenue Share, By Segment, 2017
Figure 26.Sanofi: Net Revenue Share, By Geography, 2017
Figure 27.Tandem Diabetes Care, Inc: Net Revenues, 2017-2017 ($Million)
Figure 28.Tandem Diabetes Care, Inc: Net Revenue Share, By Segment, 2017
Figure 29.Tandem Diabetes Care, Inc: Net Revenue Share, By Geography, 2017
Figure 30.Terumo Corporation: Net Revenues, 2017-2017 ($Million)
Figure 31.Terumo Corporation: Net Revenue Share, By Segment, 2017
Figure 32.Terumo Corporation: Net Revenue Share, By Geography, 2017
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|